BioCentury
ARTICLE | Clinical News

Avandia rosiglitazone: Phase III data

June 8, 2009 7:00 AM UTC

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Product: Avandia rosiglitazone Business: Endocrine Molecular target: Peroxisome proliferation activated receptor (PPAR) Description: Oral thiazo...